DIRS.INFO The most relevant business & tech news

☆ Here are Thursday's biggest analyst calls: Nvidia, Meta, Tesla, Apple, CyberArk, Grindr, Estee Lauder & more
▼ + stars: | 2024-03-28 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Here are Thursday's biggest calls on Wall Street: Wells Fargo reiterates Bank of America as overweight Wells Fargo raised its price target on Bank of America to $44 per share from $40. HSBC downgrades Bank of America to hold from buy HSBC downgraded Bank of America mainly on valuation. Benchmark reiterates Nvidia as buy Benchmark said it's standing by its buy rating on Nvidia. Bank of America reiterates Amazon as buy Bank of America said it's bullish on Amazon's investments in AI. "We are initiating coverage on CYBR with a Buy rating and a $317 PT."

Persons: Wells Fargo, Bernstein, it's, Goldman Sachs, Tesla, Goldman, Piper Sandler, Piper, Clark, Kimberly, Claude, Estee Lauder, BTIG, TD Cowen, Cowen, Grindr, William Blair, Bentley, Morgan Stanley, JPMorgan, KeyBanc, Oppenheimer, Monness Crespi Hardt downgrades Palantir, Palantir Organizations: Bank of America, FDIC, Apple, HSBC downgrades Bank of America, HSBC, of America, PNC, Tesla, EV, Kimberly, Nvidia, Amazon, Bentley Systems, Allstate, JPMorgan, Major Pharma, Citi, Boeing, Barclays, Meta, SNAP Locations: mkts, DraftKings

☆ Here are Tuesday's biggest analyst calls: Amazon, Nvidia, Reddit, Tesla, Apple, Seagate, Micron, Spotify, Gap & more
▼ + stars: | 2024-03-26 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Mizuho initiates DraftKings as buy Mizuho said in its initiation of DraftKings that it sees "upside to revenue growth." Mizuho initiates MGM as buy Mizuho said MGM shares are "fundamentally misvalued." Mizuho initiates Carnival as buy Mizuho said Carnival is a top pick at the firm. Mizuho reiterates Micron as buy Mizuho raised its price target on the stock to $130 per share from $124. "We are upgrading PAGS to Outperform from In Line with a $18 target price."

Persons: Mizuho, Bernstein, Chipotle, CFRA, Morgan Stanley, Goldman Sachs, Goldman, Levi's, it's, Wells, Richard Dickson, Katrina O'Connell, Tesla, underperform Bernstein, it's bullish, Baird, Semtech, Jefferies, underperform Jefferies, Invivyd, Evercore, TD Cowen Organizations: Mizuho, Sands, MGM, Nvidia, Blackwell, Seagate, Nasdaq, UBS, JPMorgan, Taiwan Semiconductor, Navy, Micron, MU, Citi, Plains Energy, Bank of America, Spotify, Netflix, Apple Locations: Macau, Singapore, Westar, Kansas, Missouri, Argentina, Uruguay, Paraguay, China

☆ Here are Monday's biggest analyst calls: Nvidia, Apple, Tesla, Netflix, PepsiCo, Micron, Meta, Starbucks and more
▼ + stars: | 2024-03-18 | by ( Michael Bloom | ) www.cnbc.com time to read: +8 min

Morgan Stanley reiterates Starbucks as overweight Morgan Stanley said it's standing by its overweight rating on Starbucks shares. Morgan Stanley upgrades Pepsi to overweight from equal weight Morgan Stanley said the beverage giant is undervalued. Morgan Stanley initiates Ball Corporation as equal weight Morgan Stanley initiated the beverage can company and says the stock is fairly valued right now. Morgan Stanley names LifeStance a top pick Morgan Stanley named the mental health company a top pick on Monday. Morgan Stanley reiterates Micron as underweight Morgan Stanley raised its price target on the stock to $78 per share from $74.75 and said it's sticking with its underweight rating heading into earnings later this week.

Persons: KeyBanc, Morgan Stanley, it's, Telsey, ESAB, Mizuho, Goldman Sachs, Tesla, Raymond James downgrades, Raymond James, LifeStance, Wolfe, Bernstein, Truist, Wells, Wells Fargo, F2Q Organizations: Apple, JPMorgan, 1Q, Meta, HSBC, Nvidia, Netflix, RBC, Howmet Aerospace, York Community Bank, Pepsi, Ball, Citi, Micron, IT, Downside, Bank of America, Taiwan Semiconductor, Pinnacle, of America, Pinnacle West Capital Corp, ISI, UBS, CCL Locations: Berlin, underperform, Taiwan, Arizona, Underperform

☆ Here are Friday's biggest analyst calls: Nvidia, Tesla, Apple, Rivian, Micron, Microsoft, Eli Lilly, Amazon & more
▼ + stars: | 2024-03-15 | by ( Michael Bloom | ) www.cnbc.com time to read: +8 min

Citi upgrades Thor Industries to buy from neutral Citi said it see a "favorable event path" for the RV company. " Citi initiates Pure Storage as buy Citi said in its initiation of Pure Storage that the data storage company is an AI beneficiary. Citi reiterates Apple as buy Citi said it's standing by its buy rating on shares of Apple. Bank of America reiterates Amazon as buy Bank of America said it's bullish heading into Amazon's Spring Sales event next week. Citi reiterates Micron as buy Citi raised its price target on the stock to $150 per share from $95 and says it's bullish heading into earnings next week. "

Persons: Piper Sandler, Piper, Morgan Stanley, RSG, Cummins, Baird, Nvidia, JPMorgan, Tesla, Telsey, Todd Vasos, it's, Stellantis, Five9, PBF, DINO, Truist, Eli Lilly, LLYs, Dave Ricks, Patrik Jonsson Organizations: EV, Bank of America, Adobe, Citi, Thor Industries, Morgan Stanley downgrades Republic Services, UBS, Cummins, CMI, Microsoft, Nvidia, JPMorgan, Guggenheim, Apple, Worldwide, " Bank of America, Micron, Catalyst Watch, RBC, UFC, WWE, Inc, Valero Energy, Sinclair, of America, Entertainment, Golden Entertainment, Diabetes, Obesity Locations: Snowflake, F4Q24, China, Nevada

UBS trimmed its price target on Tesla to $165 from $225, implying shares will hover around current levels for the foreseeable future. Nvidia shares have rallied more than 83% this year, building on 2024's nearly 239% gain as investors continue to bet on artificial intelligence. The firm holds an overweight rating on the stock, with its $820 price target implying about 11% downside from Wednesday's close. — Samantha Subin 5:38 a.m.: UBS trims Tesla price target, cites downside risks to deliveries UBS cut its price target on Tesla to $165 from $225 a share, citing slower electric vehicle demand in the U.S. and Europe, coupled with competition concerns in China. He also raised his price target to $68 from $55, which implies upside of 18% from Tuesday's close.

Persons: Goldman Sachs, Christopher Danely, Danely, — Samantha Subin, Joseph Spak, Spak, Wells, outperformance, Richard Ramsden, Ramsden, 2026E, Fred Imbert Organizations: CNBC, UBS, Citigroup, Citi, Nvidia, Devices, Broadcom, AMD, Micron Technology, Micron, NA Locations: U.S, Europe, China, Tuesday's

☆ Here are Friday's biggest analyst calls: Nvidia, Apple, Dell, Netflix, Micron, Broadcom, Eli Lilly, New York Community Bancorp & more
▼ + stars: | 2024-03-01 | by ( Michael Bloom | ) www.cnbc.com time to read: +8 min

"We are initiating coverage of Evolent Health with an Outperform rating and $45 price target." Goldman Sachs downgrades Estee Lauder to neutral from buy Goldman downgraded the stock and said it's under "sizeable pressure." "We are upgrading Annexon (ANNX shares) to Overweight from Neutral and establishing a December 2024 price target of $11." Bank of America reiterates Eli Lilly as buy Bank of America raised its price target on the stock to $1000 per share from $800. "Following 4Q23 earnings we are upgrading GoodRx from Neutral to Overweight and increasing our December 2024 price target from $7 to $10."

Persons: Davidson, Campbell, Morgan Stanley, JD, TD Cowen, Parker, Dell, Goldman Sachs, Goldman, Louise Singlehurst, Tom Ford, Jefferies, Root, AVGO's, Stephens, Vita Coco, COCO, Piper downgrades, Piper, Redburn, Oppenheimer, Daiwa, Morgan Stanley downgrades Flywire, Goldman Sachs downgrades Estee Lauder, Estee Lauder, Dwight, Wells, Eli Lilly, Lilly, D.A Organizations: Apple, Vulcan, Merck, Vertex Pharmaceuticals, Bank of America, Broadcom, York Community Bancorp, Netflix, Micron, Mizuho, MU, Citi, EV, Health, Nvidia, Dwight, Hewlett Packard Enterprises, JPMorgan, biosciences, " Bank of America Locations: York, Davidson, Oshkosh, Minneapolis , MN

☆ Here are Friday's biggest analyst calls: Rivian, DraftKings, Nio, Fox, Carvana, Pfizer and more
▼ + stars: | 2024-02-23 | by ( Alex Harring | ) www.cnbc.com time to read: +9 min

Here are Friday's biggest calls on Wall Street: UBS double-downgrades Rivian The firm said to sell the electric vehicle maker's stock, joining a growing group of concerned analysts following the company's earnings report. Raymond James upgrades Carvana The investment bank moved Carvana to market perform from underperform following the fourth-quarter earnings results. Guggenheim initiates Pfizer The firm opened coverage of the biopharmaceutical stock with a buy rating and $36 price target. " Rosenblatt initiates Adeia The firm began coverage with a buy rating and $15 price target. Roth MKM initiates CPI Card Group Roth MKM started coverage of the financial technology stock with a buy rating and $40 price target.

Persons: Ross, ROST, Raymond James, EBITDA, 4Q23, Guggenheim, ATNI, Morgan Stanley, Brighthouse, Rosenblatt, Roth MKM, Fred Imbert Organizations: UBS, Barclays, CNBC, Citi, Fox, JV, Ross, Price, Pfizer, DRG, Equitable, JPMorgan, Traction, JPMorgan downgrades Locations: 1Q24, Xperi, 4Q22

☆ Wall Street cheers Coinbase after its first quarterly profit in 2 years, but skepticism lingers
▼ + stars: | 2024-02-16 | by ( Tanaya Macheel | ) www.cnbc.com time to read: +8 min

Wall Street is celebrating Coinbase after the crypto exchange operator posted its first quarterly profit in two years. Late Thursday, Coinbase posted earnings of $1.04 per share on $954 million of revenue for the fourth quarter. "Happy days are here again" for Coinbase, as Raymond James put it, but it's not clear for how long. "That said, we maintain our U/P rating given crypto market unpredictability, lack of revenue diversification, valuation, and continued legal overhang." JPMorgan, neutral, PT $95 "Management calls spot bitcoin ETFs [a] net positive but, we're still unconvinced," said JPMorgan's Kenneth Worthington.

Persons: Coinbase, haven't, bitcoin, Raymond James, Goldman Sachs, Goldman, Will Nance, revs, Jason Kupferberg, Benjamin Budish, EBITDA, underperform, Patrick O'Shaughnessy, we're, Kenneth Worthington, Keefe, KBW's Kyle Voigt, Oppenheimer, Owen Lau, Devin Ryan, Needham, John Todaro, Canaccord, Joseph Vafi, Michael Bloom Organizations: LSEG, U.S . Securities, Exchange Commission, " Bank of America, Bank of America, Barclays, JPMorgan, Management, SEC, Coinbase's, BTC Locations: U.S, Coinbase, Needham

☆ These companies have earnings momentum heading into their reports next week
▼ + stars: | 2024-01-25 | by ( Pia Singh | ) www.cnbc.com time to read: +3 min

A fresh batch of earnings are set to come out next week, ranging from Big Tech companies to major pharmaceutical names, and analysts think some names could post stand-out results. Roughly 19% of S & P 500 companies are set to report next week, including megacap names such as Apple, Microsoft and Amazon. Thus far, about 22% of companies have reported earnings for the fourth quarter, with nearly 74% of those names surpassing expectations, FactSet data shows. Nearly 20 analysts have revised their quarterly earnings estimates upward. Other companies that have earnings momentum heading into next week include Hartford Financial Services and A. O. Smith Corporation , both of which have received roughly 20 earnings estimate revisions in the past three months.

Persons: FactSet, Brent Thill, Thill, AMZN, Tal Liani Organizations: Big Tech, Apple, Microsoft, CNBC, Jefferies, Amazon, MGM Studios, Royal, Qualcomm, Bank of America, Hartford Financial Services, Smith Corporation Locations: Wednesday's

☆ Oil prices dip on weak demand, strong dollar
▼ + stars: | 2024-01-24 | by ( ) www.cnbc.com time to read: +3 min

File: A Repsol Oil Operations oil drilling rig pounds into the desert searching through thousands of feet for and oil reserve in El-Sharara, Libya. Oil prices edged lower on Wednesday, weighed down by concerns over tepid demand and a stronger dollar even though escalating geopolitical tensions limited the losses. Gasoline inventories, however, increased by 7.2 million barrels, stoking concerns over fuel demand in the world's top oil consumer. A stronger U.S. dollar also weighed on oil prices as demand from buyers in other currencies ebbs as they have to pay more for dollar-denominated oil. Elsewhere, U.S.'s third-largest oil-producing state of North Dakota brought some oil output back online after weather-related disruption, the state's pipeline authority said.

Persons: Vikas Dwivedi Organizations: Operations, Brent, . West Texas, American Petroleum Institute, The Energy Information Administration, U.S . Department of Energy, Federal Reserve, Macquarie, U.S, Houthi, Sharara, Jan Locations: El, Sharara, Libya, Russia, Ukraine, Yemen, Britain, U.S, Iran, Red, Iraq, Iraqi, North Dakota

☆ Here are Wednesday's biggest analyst calls: Apple, Netflix, Nvidia, Uber, Tesla, Microsoft, Amazon & more
▼ + stars: | 2024-01-24 | by ( Michael Bloom | ) www.cnbc.com time to read: +7 min

Here are Wednesday's biggest calls on Wall Street: Citi reiterates Chipotle as buy Citi raised its price target on Chipotle to $2,699 per share from $2,292. "We are launching coverage of NKLA with an Outperform rating and a $2 price target." Polestar : On a Road to Nowhere - Initiating Coverage with a target price of $1.15, Underperform." Citi upgrades Sunoco to buy from neutral Citi said the oil and gas company is "compelling." Citi reiterates Microsoft as buy Citi raised its price target on the stock to $470 per share from $432 and said "ramping GenAI should keep growth accelerating."

Persons: Chipotle, Daiwa, Wells, Morgan Stanley, it's, Baird, Nikola, Bernstein, Biogen, Webster, Redburn, Tesla, Apple, Morgan Stanley downgrades PagerDuty, Gordon Haskett downgrades Uber, Gordon Haskett, Oppenheimer, PulteGroup, Wolfe Organizations: Citi, Verizon, Netflix, Amazon, EV, Devices, AMD, UBS, Apple, Uber, Deutsche Bank, Deutsche, Barclays downgrades, Barclays, Microsoft, BMO, HSBC, Stellantis, Entertainment, Nvidia, Wolfe Alpha, Valero, Phillips Locations: H1'24, Nowhere, China

☆ Citi says buy this little-known biotech stock with nearly 60% upside
▼ + stars: | 2023-12-05 | by ( Pia Singh | ) www.cnbc.com time to read: +2 min

Battered-down biotechnology stock Travere Therapeutics could see a strong turnaround, according to Citi. Analyst Carly Kenselaar upgraded the clinical-stage company to buy/high risk and raised her price target by $3 to $10, which suggests shares could climb nearly 59% over the next 12 months. Kenselaar's new rating comes after some positive signals indicate the company is on track to obtaining full approval for its Filspari drug. "With the stock trading below cash, we believe risk/reward is skewed quite favorably into a full approval decision, supporting our upgrade," Kenselaar wrote in a Tuesday note. The move would extend its cash runway into 2028, the company said, which Kenselaar pointed to as another catalyst for her increased price target.

Persons: Carly Kenselaar, Kenselaar, Filspari, Travere Organizations: Citi, U.S . Food, FDA Locations: U.S

Bernstein named Taiwan Semiconductor a "best idea" for 2024, raising its price target on the stock. — Alex Harring 7:01 a.m. In addition to the best-pick honor, analyst Steve Scala has an outperform rating and $86 price target. Analyst Michael Lavery downgraded the stock to neutral from overweight and slashed his price target by $40 to $200. ET: Morgan Stanley hikes PDD price target, calls stock a top pick following earnings Morgan Stanley named Chinese e-commerce name PDD Holdings a top pick following its latest quarterly earnings report.

Persons: Bernstein, Morgan Stanley, LSEG, Bank of America's Tal Liani, Morgan Stanley's Hamza Fodderwala, Alex Harring, Craig Siegenthaler, Blackstone, That's, — Alex Harring, Ken Hoexter, Hoexter, TD Cowen, Steve Scala, Scala, Jefferies, John Colantuoni, bode, Colantuoni, Neil Beveridge, Josh Silverstein, Silverstein, JMP, Baldwin, Mitch Germain, Germain doesn't, Germain, Piper Sandler, Michael Lavery, Lavery, elasticities, HSY's, Hershey, Eddy Wang, Wang, Mark Li, Li, — Fred Imbert Organizations: CNBC, Taiwan Semiconductor, Holdings, Wall, Bank of America, Bank of America's, KKR, Apollo Global Management, Pacific, Transport, AstraZeneca, pharma, Airbnb, Toyota, UBS, Exxon Mobil, Natural Resources, Exxon Mobil's, Hershey, PDD, U.S, LSEG, Commerce, PDD's U.S, Apple, Huawei Locations: Tuesday's, Ivory Coast, Ghana, 4Q23, Taiwan, China

☆ Brent slips toward $80/bbl ahead of OPEC+ meeting
▼ + stars: | 2023-11-27 | by ( Florence Tan | ) www.reuters.com time to read: +3 min

The sun is seen behind a crude oil pump jack in the Permian Basin in Loving County, Texas, U.S., November 22, 2019. REUTERS/Angus Mordant/File Photo Acquire Licensing RightsSINGAPORE, Nov 27 (Reuters) - Oil prices slipped on Monday, with Brent falling toward $80 a barrel, as investors awaited the OPEC+ meeting later this week for an agreement to curb supplies into 2024. Since then, the group has moved closer to a compromise, four OPEC+ sources told Reuters on Friday. Ahead of the OPEC+ meeting, estimated exports by OPEC countries have declined to 1.3 million barrels per day below levels in April, Goldman Sachs analysts said in a note, in line with the group's supply targets. The International Energy Agency said it expects a slight surplus in global oil markets in 2024 even if the OPEC+ nations extend their cuts into next year.

Persons: Angus Mordant, Brent, Goldman Sachs, Vivek Dhar, Florence Tan, Sonali Paul Organizations: REUTERS, Rights, Brent, U.S, West Texas, Organization of, Petroleum, Reuters, Friday, ING, OPEC, United, International Energy Agency, Commonwealth Bank, IEA, Thomson Locations: Loving County , Texas, U.S, Rights SINGAPORE, OPEC, Saudi Arabia, Russia, Saudi, United Arab Emirates, Gaza

☆ Oil set for third weekly decline as demand worries weigh
▼ + stars: | 2023-11-10 | by ( Ahmad Ghaddar | ) www.reuters.com time to read: +2 min

The sun is seen behind a crude oil pump jack in the Permian Basin in Loving County, Texas, U.S., November 22, 2019. Both contracts are set to fall about 5% on the week. "Concerns about demand have replaced the fear of production outages related to the Middle East conflict," Commerzbank said. Weak Chinese economic data this week increased worries of faltering demand. Additionally, refiners in China, the largest buyer of crude oil from the world's largest exporter Saudi Arabia, asked for less supply from Saudi Arabia for December.

Persons: Angus Mordant, Commerzbank, Helima Croft, Sudarshan Varadhan, Nick Macfie Organizations: REUTERS, Brent, U.S, West Texas, of, Petroleum, RBC Capital Markets, Citi, Thomson Locations: Loving County , Texas, U.S, refiners, China, Saudi Arabia, Russia, Singapore

☆ Jefferies upgrades this little-known biotech stock with more than 100% upside
▼ + stars: | 2023-11-10 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +1 min

The firm upgraded shares of the late-stage biotech to buy from hold, lifting its price target to $26 from $18. Shares of Vera Therapeutics have fallen 37.8% this year, but analyst Farzin Haque believes the stock's recent pullback now means an attractive entry point for investors. VERA YTD mountain VERA YTD chart "W/ shares down –30% (vs XBI –13%) since Sept 21 TVTX data release, we have become more optimistic about atacicept (dual BAFF/APRIL) clin profile," Haque wrote. Atacicept, which Vera took over from Merck, is a drug that treats certain autoimmune diseases. "W/ recent increasing focus on eGFR, VERA's OLE data from ph.II for longer-term eGFR data (expected 1Q24) has now become an important catalyst for the stock," Haque said.

Persons: Vera, Jefferies, Vera Therapeutics, Farzin Haque, VERA YTD, VERA, Haque, Lupus nephritis, — CNBC's Michael Bloom Organizations: Vera, Merck Locations: ph.II

☆ AMD stock jumps more than 8% on strong 2024 AI chip projections
▼ + stars: | 2023-11-01 | by ( Jake Piazza | In | ) www.cnbc.com time to read: +2 min

AMD stock spiked more than 8% Wednesday, a day after the company beat top and bottom-line earnings estimates and gave a promising 2024 forecast for its AI chip business. The chipmaker posted an earnings per share of 70 cents, adjusted, narrowly beating the LSEG, formerly Refinitiv, estimate of 68 cents per share. Wall Street analysts like AMD's prospects in the AI market, which is currently dominated by Nvidia . Still, AMD is one of only a handful of companies capable of making high-powered graphics processing units (GPUs) that power AI models. Analysts at Raymond James lowered their price target from $145 to $125 but kept AMD as a "strong buy" largely due to its AI business.

Persons: Lisa Su, Raymond James, Jeffries, CNBC's Kif Leswing, Michael Bloom Organizations: Devices Inc, AMD, Revenue, Wall Street, Nvidia, Bank of America Locations: San Francisco , California, U.S, Q4E, CY24E, 1Q24

☆ Buy this regional bank stock that has been 'caught in the storm,' Citi says
▼ + stars: | 2023-09-29 | by ( Hakyung Kim | ) www.cnbc.com time to read: +3 min

However, Citi thinks the stock has been "caught in the storm" and sees upside potential ahead. Following the failure of Silicon Valley Bank, Zions got caught in a broader panic among regional banks, which led to deposit outflows and funding pressures. 31, 2023, the bank's core deposits fell by nearly 10% to about $64 billion, according to Citi. "ZION has been impacted by deposit outflows, but we find that ZION's core deposits (excluding broker deposits) ranks second lowest on cumulative beta on total deposits so far this cycle. ZION reported positive trends towards the end of 2Q as core deposits were up 3% sequentially," Horowitz said.

Persons: Zions Bancorporation, Keith Horowitz, Zions, Horowitz, ZION, CNBC's Michael Bloom Organizations: Citi, Silicon Valley Bank, Watch, Management Locations: Silicon, Mar, Zions, 4Q23, NII, ZION

☆ Buy this pharma stock that could more than double if it clears a legal battle, Jefferies says
▼ + stars: | 2023-09-20 | by ( Sarah Min | ) www.cnbc.com time to read: +2 min

Investors should buy Bausch Health Companies as shares can more than double from here, Jefferies said. Bausch Health is embroiled in a legal battle over Xifaxan, its drug for irritable bowel syndrome with diarrhea, to prevent generics from entering the market. Bausch Health has been hoping to spin off its valuable vision care unit, Bausch + Lomb, for several years. Bausch Health shares are higher this year by more than 22%. The analyst cited other reasons why Bausch Health shares will get a boost.

Persons: Jefferies, Glen, mgt, Santangelo, Bausch, — CNBC's Michael Bloom Organizations: Health Companies, Health, Bausch Health, FDA Locations: Xifaxan, Norwich, Bausch, New Jersey

☆ The stock market's 'no recession' relief rally is over. Expect flat markets for the rest of the year.
▼ + stars: | 2023-08-10 | by ( Matthew Fox | ) www.businessinsider.com time to read: +3 min

The "no recession relief rally" has ended for the stock market, according to Stifel's Barry Bannister. The S&P 500 is up about 17% year-to-date, but has declined by about 3% since the start of August. Bannister expects the S&P 500 to finish the year at 4,400, suggesting potential downside of about 2% from current levels. According to data from Bank of America, stock market returns are typically muted between July and December in the third year of the Presidential Cycle, which reference a four-year stock market cycle that tracks with the four-year term of the US President. That's well below consensus estimates of the S&P 500 generating $226 in earnings per share next year.

Persons: Stifel's Barry Bannister, Bannister, Barry Bannister, committement, wouldn't, Stephen Suttmeier Organizations: Service, Federal, Bank of America Locations: Wall, Silicon

☆ Macquarie flags lower quarterly profit as commodities arm flounders
▼ + stars: | 2023-07-27 | by ( Harish Sridharan | ) www.reuters.com time to read: +2 min

Macquarie's Commodities and Global Markets (CGM) unit, its biggest earner, has for several years cashed in on increasing hedging activity amid volatility in oil and gas markets. That had driven the Sydney-based firm's annual earnings to a record A$5.18 billion ($3.53 billion) in fiscal 2023 ended March. While Macquarie did not disclose a profit figure in its quarterly update, Citi Research had expected first-quarter earnings of around A$1 billion ($680.90 million). The analysts noted, however, that Macquarie's earnings may have come in below that. At the end of the quarter, Macquarie's capital surplus stood at A$10.8 billion.

Persons: Shemara Wikramanayake, Macquarie, Harish Sridharan, Navya Mittal, Echha, Subhranshu Sahu, Christopher Cushing Organizations: Macquarie, Citi, Macquarie Group, Macquarie's Commodities, Global Markets, Citi Research, Thomson Locations: Sydney, Bengaluru

☆ JPMorgan's top equity guru says buy more government bonds, avoid stocks as a recession looms at the turn of the year
▼ + stars: | 2023-07-11 | by ( Sarah Min | ) www.cnbc.com time to read: +1 min

Investors should buy more government bonds to brace for the likelihood of a recession hitting later this year, JPMorgan's top equity strategist says. Investors are increasingly deserting defensive positions as more market participants expect a soft landing scenario for the economy. But JPMorgan's Marko Kolanovic said investors are mistaken and continues to see a year-end recession as his base case outlook. "This benign and complacent pricing of recession risk, along with increasing signs that a credit cycle is emerging, makes us turn more negative on corporate bonds and more positive on government bonds," Kolanovic wrote to clients Monday. "We therefore trim our allocation to credit by shifting two percentage points away from corporate bonds and into government bonds in our model portfolio," Kolanovic wrote.

Persons: JPMorgan's Marko Kolanovic, Kolanovic Organizations: Nasdaq Locations: 4Q23

☆ Wall Street is worried the stock market is already overvalued
▼ + stars: | 2023-06-22 | by ( John Melloy | ) www.cnbc.com time to read: +3 min

Even as the stock market is just trying to claw its way out of a bear market, multiple Wall Street firms on Thursday raised concerns that equities are already overvalued. Following a breakout in the past month, the S & P 500 is up more than 20% from its October low and is at a 13-month high. But while an official bull market is not yet confirmed (S & P 500 needs to hit a new all-time high for that), the stock market may already be overvalued, some major strategists said. .SPX ALL mountain S & P 500 long term The S & P 500 is trading at forward price-earnings ratio of 18.8, compared to the average valuation of 15.4 times the last four decades, according to UBS. Nevertheless, normally uber-bullish Wall Street is having trouble seeing boom times ahead for equity investors with valuations already so high.

Persons: Solita Marcelli, annualized, Jonathan Golub, Michael Bloom Organizations: UBS, Global Wealth Management, Americas, JPMorgan, Credit Suisse

☆ Turkey stocks rally, lira slips to record low after Erdogan victory
▼ + stars: | 2023-05-29 | by ( ) www.reuters.com time to read: +7 min

The nation is grappling with a cost of living crisis, a plunging currency and depleted foreign reserves. MARKET REACTION:LIRA: The Turkish currency touched a fresh record low of 20.105 on Monday. "In a scenario where Turkey ran out of foreign currency, lira’s value would likely collapse, inflation would explode and goods shortages could occur. A painful crisis affecting all assets is on the way, with very high inflation, very low interest rates and no net foreign reserves. Only the most optimistic would hope that Erdogan now feels sufficiently secure politically to revert to orthodox economic policy."

☆ Here are Monday's biggest analyst calls: Apple, Amazon, Tesla, Macy's, Netflix, Sunnova, Intel & more
▼ + stars: | 2023-04-03 | by ( Michael Bloom | ) www.cnbc.com time to read: +7 min

Morgan Stanley initiates Sunnova as overweight Morgan Stanley said it sees 124% upside for the solar company. " Morgan Stanley downgrades First Solar to underweight from equal weight Morgan Stanley downgraded the stock mainly on valuation. Bank of America adds Lowe's to the US 1 list Bank of America added the home improvement giant to its top ideas list. Bank of America names Netflix a top second-quarter pick Bank of America said it's bullish on the streaming giant as the second quarter begins. Morgan Stanley downgrades Marqeta to equal weight from overweight Morgan Stanley said in its downgrade of the card payment and solutions company that it sees too many negative catalysts. "

Search resuls for: "1Q24"

25 mentions found